Target Gene/Pathway💬 Info on mouse-over

17 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Aldosterone synthesis and secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
2 Aldosterone synthesis and secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
3 Calcium signaling pathway 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
4 Calcium signaling pathway 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
5 cAMP signaling pathway 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
6 Circadian entrainment 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
7 Circadian entrainment 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
8 Circadian entrainment 💬
[2] MTNR1A, MTNR1B 💬 D08170 💬 Melatonin [11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
9 Cortisol synthesis and secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
10 Cortisol synthesis and secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
11 Cushing syndrome 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
12 Cushing syndrome 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
13 ECM-receptor interaction 💬
[1] SV2A 💬 D08879 💬 Brivaracetam [2] 149, 309 💬
14 ECM-receptor interaction 💬
[3] SV2A, SV2B, SV2C 💬 D11842 💬 Padsevonil [1] 149 💬
15 Estrogen signaling pathway 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
16 GABAergic synapse 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
17 GnRH secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
18 GnRH secretion 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
19 GnRH secretion 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
20 Insulin secretion 💬
[1] SNAP25 💬 D00783 💬 Botulinum toxin type A [13]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
21 MAPK signaling pathway 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
22 MAPK signaling pathway 💬
[3] CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬
23 Morphine addiction 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
24 Neuroactive ligand-receptor interaction 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
25 Neuroactive ligand-receptor interaction 💬
[2] MTNR1A, MTNR1B 💬 D08170 💬 Melatonin [11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
26 Synaptic vesicle cycle 💬
[1] SNAP25 💬 D00783 💬 Botulinum toxin type A [13]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
27 Taste transduction 💬
[2] GABBR1, GABBR2 💬 D00241 💬 Baclofen [5]  2 , 10, 13, 18, 149 💬
28 Taste transduction 💬
[2] SCN3A, SCN9A 💬 D07299 💬 Lacosamide [3]  2 , 46, 149 💬
29 Type II diabetes mellitus 💬
[1] CACNA1G 💬 D01303 💬 Flunarizine [4] 58, 86, 149, 215 💬
30 Type II diabetes mellitus 💬
[1] CACNA1G 💬 D07971 💬 Flunarizine [4] 58, 86, 149, 215 💬